DeepMed Research

Abramson Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.pennmedicine.org

Clinical Trials

Cigar Packaging Study

Not Applicable

Completed

Conditions: Smoking

Interventions: Other: Package Quantity (cigarillos)

First Posted Date: 2020-10-28

Last Posted Date: 2023-02-27

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 51

Registration Number: NCT04605874

Locations: 🇺🇸
Center for Interdisciplinary Research for Nicotine Addiction, Philadelphia, Pennsylvania, United States

ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer

Phase 2

Recruiting

Conditions: Breast Cancer

Interventions: Drug: Abemaciclib
Drug: Hydroxychloroquine

First Posted Date: 2020-08-24

Last Posted Date: 2025-04-04

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 66

Registration Number: NCT04523857

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

BRCA1/2 Flu Vaccine

Active, not recruiting

Conditions: BRCA1 Mutation
BRCA2 Mutation

First Posted Date: 2020-08-05

Last Posted Date: 2024-11-05

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 50

Registration Number: NCT04499534

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Low-Level Laser in Head and Neck Chronic Lymphedema

Not Applicable

Completed

Conditions: Head and Neck Cancer
Fibrosis
Lymphedema

Interventions: Device: Low-level laser

First Posted Date: 2020-07-23

Last Posted Date: 2024-11-19

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 25

Registration Number: NCT04482855

Locations: 🇺🇸
University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania, United States

BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy

Phase 1

Recruiting

Conditions: Breast Cancer

Interventions: Radiation: Hypofractionated radiotherapy
Drug: Pembrolizumab infusion
Procedure: Blood and tissue sampling

First Posted Date: 2020-07-01

Last Posted Date: 2024-04-22

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 27

Registration Number: NCT04454528

Locations: 🇺🇸
Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States

Physiologic MR Imaging of Salivary Gland Tumors

Not Applicable

Recruiting

Conditions: Salivary Gland Tumor

Interventions: Diagnostic Test: MRI

First Posted Date: 2020-06-30

Last Posted Date: 2025-02-07

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 30

Registration Number: NCT04452162

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary

Phase 1

Terminated

Conditions: Renal Cell Carcinoma
Renal Cell Carcinoma Stage IV

Interventions: Drug: Nivolumab
Drug: Ipilimumab
Device: bland embolization

First Posted Date: 2020-06-12

Last Posted Date: 2024-04-26

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 1

Registration Number: NCT04429321

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Li-Fraumeni Syndrome/TP53 Biobank

Recruiting

Conditions: Li-Fraumeni-Like Syndrome
Li-Fraumeni Syndrome

Interventions: Other: No Intervention

First Posted Date: 2020-04-29

Last Posted Date: 2024-07-19

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 300

Registration Number: NCT04367246

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Cardiotoxicity in Breast Cancer Patients Treated with Proton or Photon Radiotherapy: a RadComp Companion Study

Active, not recruiting

Conditions: Breast Cancer
Cardiotoxicity

Interventions: Radiation: Proton vs Photon Radiation

First Posted Date: 2020-04-24

Last Posted Date: 2024-10-10

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 175

Registration Number: NCT04361240

Locations: 🇺🇸
Northwestern Medicine, Warrenville, Illinois, United States
🇺🇸
Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 3 locations

Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer Patients

Not Applicable

Active, not recruiting

Conditions: Cancer

Interventions: Other: Standard of Care
Other: Pre-Test Intervention
Other: Post-Test Intervention

First Posted Date: 2020-04-21

Last Posted Date: 2025-04-06

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 256

Registration Number: NCT04353973

Locations: 🇺🇸
Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy